{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-228074","form_type":"8-K","ticker":"IVVD","cik":"0001832038","company_name":"Invivyd, Inc.","filed_at":"2023-09-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.571630+00:00","generated_at":"2026-06-11T00:09:52.027299+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Invivyd appoints William Duke as CFO effective September 1, 2023","bullets":["William Duke (51) appointed CFO; previously CFO at Apexigen and Kaleido Biosciences.","Salary $475,000, initial target bonus 40% of salary, $20,000 signing bonus.","Received option to purchase 750,000 shares vesting over 4 years.","Duke led Apexigen through its sale to Pyxis Oncology and completed multiple financings.","CEO Hering cited Duke's experience as valuable for upcoming VYD222 clinical study and potential EUA submission."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-228074","json":"https://secwatch.observer/filing/0001193125-23-228074.json","markdown":"https://secwatch.observer/filing/0001193125-23-228074.md","text":"https://secwatch.observer/filing/0001193125-23-228074.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1832038/000119312523228074/0001193125-23-228074-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1832038/000119312523228074/d539466d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T00:09:52.027299+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e3cba6c4d6","claim":"William Duke was appointed as Chief Financial Officer at Invivyd, Inc..","evidence_excerpt":"On September 5, 2023, Invivyd, Inc. (the “Company”) announced the appointment of William Duke, age 51, as the Company’s Chief Financial Officer, effective as of September 1, 2023","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832038/000119312523228074/0001193125-23-228074-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}